I wanted to sell at one point, expecting value to drop like a rock due to sharply declining sales of Covid vaccines. But they’ve been investing heavily in other areas, especially in those where revolutionary development was triggered by mNRA research, such as oncology, immunology and genetic diseases. They expect to have at least 8 blockbuster oncology dr-gs by 2030. I’m still on board.
There are no replies in this thread yet. Be the first to post a reply below: